Juan Wang
Second Affiliated Hospital, Zhejiang University, School of Medicine · First Affiliated Hospital Xi'an Jiaotong University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Juan Wang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:52 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07716228 · Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-boundSecond Affiliated Hospital, Zhejiang University, School of Medicine · recruiting · Nausea and Vomiting Caused by Chemotherapy · study chair
- Ph3NCT07716176 · Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Docetaxel Plus CyclophosphamideSecond Affiliated Hospital, Zhejiang University, School of Medicine · recruiting · Nausea and Vomiting Caused by Chemotherapy · study chair
- Ph2NCT07537699 · Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus CyclophosphamideSecond Affiliated Hospital, Zhejiang University, School of Medicine · recruiting · Nausea and Vomiting Caused by Chemotherapy · study chair
- N/ANCT03257475 · Evaluation of Vaginal Dose in Cervical Cancer Patients Treated With RadiotherapyXi'an Jiaotong University · unknown · Cervical Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:52 UTC. The ranking covers the 200 most relevant of 5726 PubMed records, and a shared surname and initials can bring in a namesake. All 5726 on PubMed
- 131 citationsRCR 36.7
- Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC.N Engl J Med · 2026107 citationsRCR 53.5
- Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial.Nat Med · 202538 citationsRCR 7.3
- Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.J Clin Oncol · 202538 citationsRCR 7.8
- 28 citationsRCR 14.0
- Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.Nat Med · 202628 citationsRCR 14.0
- 22 citationsRCR 11.0
- 21 citationsRCR 3.7
- Long-Term Outcomes of Left Bundle-Branch Pacing vs Biventricular Pacing in Heart Failure: The HeartSync-LBBP Randomized Clinical Trial.JAMA Cardiol · 202621 citationsRCR 10.5
- Endovascular Treatment of Medium-Vessel-Occlusion Strokes.N Engl J Med · 202620 citationsRCR 10.0